A/Prof Ashwin Subramaniam

[Prof Daryl Jones @jones_daza]

Latest offering
SRMA of in-hospital cardiac arrests in ICU
These are very different to IHCAs on the ward

https://t.co/lXQIOu4SXv
https://t.co/g8ntN6Qb3i
https://t.co/ImhJ5NRz5S

@catchdrash @JuditOrosz4 @PoundGemma

[ANZICS @anzics]

Preliminary Program Now Available!

We’re excited to announce that the preliminary program for the upcoming Safety and Quality Conference is now live.

👉 https://t.co/rQPr55EuEn

This year’s theme, “Care 365: Our Patients. Our Staff. Our Environment”, reflects our unwavering commitment to delivering safe, high-quality care in intensive care.

The program features a dynamic lineup of keynote speakers, interactive sessions, and thought-provoking panels designed to inspire and empower healthcare professionals across all disciplines. Explore topics including:
🔹 Patient-centred care innovations
🔹 Staff well-being
🔹 Sustainable healthcare practices
🔹 System-wide quality improvement strategies

Whether you’re an Intensivist, nurse, allied health professional, or research coordinator — this conference has something for you.

👉 Don’t miss out! Register now and be part of the conversation shaping the future of safety and quality in healthcare.

https://t.co/gOv34WZfmz

#SafetyAndQuality #IntensiveCare #HealthcareInnovation #ANZICS

[ANZICS @anzics]

🚨 Less Than 1 Month to Go! 🚨

The countdown is on for the 2025 Safety & Quality Conference – Care 365.
While the early bird window has now closed, there’s still time to secure your place!
Join leading clinicians, innovators, and changemakers in Sydney from October 9–11 as we explore the future of safety, quality, and sustainability in intensive care.

👉 Register now: https://t.co/FBe3roO3wP

#ANZICS #Care365 #SafetyAndQuality #ICU

[Hayley Gershengorn @HBGMD]

Both delirium 😵‍💫 & frailty 🚫💪 are important predictors of mortality in ICU patients… but do they interact to associate w harm?

👀 at @catchdrash et al’s new study, just out in #journal_CHESTCritCare, to find out:

https://t.co/DzpQ6RyjkZ

[Intensive Care Medicine @yourICM]

Outcome of #IHCA in periop vs ward settings
🔍@anzics dataset 🇦🇺 >5.6K IHCAs
🔪38% periop IHCA: younger, less frail/comorbid, most frequently admitted after CV, GI, #trauma surgery
🪦periop: better survival 59.9% vs 33%, all subgroups
🔓https://t.co/9JyFDarDrj
⬇️visual abstract

[Ryo Ueno @Intensive_Ryo]

and...an open access! 🔓 @anzics @yourICM @catchdrash @IntensiveDave @jones_daza

[David Pilcher @IntensiveDave]

An ICM highlight paper by @Intensive_Ryo & @anzics at #ESICM @ESICM Great summary by @CombesProf

[Critical Care Research Group @CCRG_Research]

Countdown is on to @CritCareReviews Down Under!

🇦🇺Discover the world's best clinical trials all in one place
🐨 Extensive scientific and social program
🦘No need to travel to Belfast!

CCR Down Under
10 & 11 Dec 2024
Melbourne, Australia

Register now
https://t.co/m5Q9GgOnJi

[Ryan Ruiyang Ling @ryanryling]

I believe that #ECMO is a life-saving temporising intervention. Yet, there are ethical dilemmas when it appears "futile".

In @LancetRespirMed, @kshekar01 @KrKrramanathan and I envision a future where ECMO can be reliably used as a long-term device.

https://t.co/YqY2YzkVfQ

[Ryan Ruiyang Ling @ryanryling]

🧐 What is the burden of AHRF in ICUs?
🫂 ANZICS APD 2005-2024: 1.5m patients with ABGs
🫁 >50% had AHRF within 24h of ICU admission!
🪦 Mortality ⬆️with worsening P/F ratios, esp <200.
⏲️ Mortality ⬇️ with time, but not unique to AHRF alone...
🔓 https://t.co/gz9zOnxgn2
#FOAMed

[Intensive Care Medicine @yourICM]

Acute hypoxemic respiratory failure in #ICU in 🇦🇺🇳🇿: disease burden may be higher than expected!
🪦mortality ⬆️ with ⬇️ P/F, particularly <200: need to reconsider how we stratify AHRF severity?
🪦mortality ⬇️ over time: improvements in critical care?
🔓 https://t.co/QPKCupESkj

[Ryo Ueno @Intensive_Ryo]

4y survival of #IHCA in perioperative vs ward settings

Are they different?🙋‍♂️
what if intubated? 🫀
What if elderly? 👴
What if after emergency surgery? 🆘

Check this out 🆕 @yourICM

[Intensive Care Medicine @yourICM]

Outcome of #IHCA in perioperative vs ward settings
🔍@anzics dataset 🇦🇺: >5.6K IHCAs
🔪38% periop IHCA: younger, less frail/comorbid, most frequently admitted after CV, GI, #trauma surgery
🪦periop: longer 4y survival 59.9% vs 33% across all subgroups
🖇️ https://t.co/KeR74G6huX

[Prof Daryl Jones @jones_daza]

Well done @Intensive_Ryo @catchdrash
Very important work highlighting the importance of
1. the association of frailty with outcomes of IHCA
2. deploying CPR in appropriate patients
3. the need to have goals of care discussions with inpatients

[A/Prof Ashwin Subramaniam @catchdrash]

@PeninsulaHealth @MonashUni @anzics @anzicrc @NCHealthyAgeing @

[Ryo Ueno @Intensive_Ryo]

Frail pt admitted to ICU after in-hospital-cardiac-arrest 🆘 🏥

What is one-year survival? ⏱️

How much is frailty associated with mortality compared to other risk factors? 👴

Check this out! https://t.co/nS11TlECKW

@jones_daza @IntensiveDave @catchdrash @anzics @anzicrc

[Ryo Ueno @Intensive_Ryo]

Frail pt admitted to ICU after in-hospital-cardiac-arrest 🆘 🏥

What is one-year survival? ⏱️

How much is frailty associated with mortality compared to other risk factors? 👴

Check this out! https://t.co/nS11TlECKW

@jones_daza @IntensiveDave @catchdrash @anzics @anzicrc

[Peninsula Health @PeninsulaHealth]

Published in @TheLancet , a recent study undertaken by Peninsula Health specialists Dr Mallikarjuna Ponnapa Reddy, A/Prof Ashwin Subramaniam and their team has suggested some significant COVID-19 related findings. https://t.co/6rBA9zjAHP

[Ryan Ruiyang Ling @ryanryling]

With an excellent, insightful commentary by Marcus Schultz, David van Meenen, and @Acute_Pulmo_Med on the lessons learnt during the pandemic.

[Ramanathan KR @KrKrramanathan]

- No compliance based subphenotypes observed in COVID-related ARDS
- Making changes to conventional ventilatory strategies/adopting newer strategies based on scarce evidence in emerging infectious respiratory pathologies can be deleterious.@LancetRespirMed

[Ryan Ruiyang Ling @ryanryling]

New meta-analysis on #COVID #ARDS #phenotypes out in @LancetRespirMed:

🫁 compliance is NORMALLY distributed
📠 vent. management for #COVID #ARDS should not differ from non-COVID-19 ARDS
👨‍👩‍👧‍👦 more patient-level analyses needed

https://t.co/FxDe12yWhc